# APAC Pharmaceutical Glass Packaging Market > Asia Pacific Pharmaceutical Glass Packaging Market Research Report Information By Product (Vials & Ampoules, Cartridges, Bottles, and Syringes), By Drug Type (Generic, Branded and Biologic) –and Asia Pacific Market Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.13% - **2024:** $ 8,019.57 Million - **2025:** $ 8,591.37 Million - **2035:** $ 17,100 Million - **Key Players:** Schott AG (DE), Corning Inc (US), Gerresheimer AG (DE), Nipro Corporation (JP), Owen Mumford Ltd (GB), Ardagh Group (IE), Stölzle-Oberglas GmbH (AT), Saverglass (FR) **Report ID:** MRFR/PCM/20060-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** April 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/apac-pharmaceutical-glass-packaging-market-21658 --- ## Market Summary ## **Asia Pacific Pharmaceutical Glass Packaging Market Overview** Asia Pacific Pharmaceutical Glass Packaging Market Size was valued at USD 19.96 Billion in 2024. The Pharmaceutical Glass Packaging industry is projected to grow from USD 21.40 Billion in 2025 to USD 40.01 Billion by 2034, exhibiting a compound yearly growth rate (CAGR) of 7.20% during the forecast period (2025 - 2034). The adoption of new glass types in order to reduce product contamination is the major market driver driving the Pharmaceutical Glass Packaging market in Asia Pacific. The pharmaceutical industry is growing rapidly due to the exponential growth of population, rising spending on public healthcare systems, and surging awareness of health. Source: The Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Pharmaceutical Glass Packaging Market Trends** The Asia Pacific Pharmaceutical Glass Packaging market CAGR is expanding due to the growing pharmaceutical industry in developing economies. The emerging economies in the region have been witnessing an increase in pharmaceutical consumption and manufacturing owing to different factors like rising population and growing healthcare requirements, leading to an increased demand for pharmaceutical products. Moreover, the improving healthcare infrastructure, rising income levels, and surging middle-class population help in broadening the pharmaceutical sector in the Asia Pacific region. As a result, there is an increased demand for high-quality packaging solutions for ensuring the efficacy, safety, and integrity of pharmaceutical products. Glass packaging has become a preferred option for pharmaceuticals because of its inert nature, minimizing the risk of chemical reactions between the container and contents, as it provides prime barrier features by protecting the drugs from oxygen, moisture and other external factors which can deteriorate their stability. Glass packaging is eco-friendly and recyclable which aligns with the global sustainability trend. Furthermore, the advancements in glass manufacturing technologies have resulted in the development of new and innovative packaging designs catering to the demands of pharmaceutical industries. This improves the usability, functionality, and aesthetics of glass packaging, hence boosting market growth. Moreover, transparency is provided by the glass packaging as it allows for easy inspection of content, which is essential for making sure that the product aligns with the regulatory standards. Also, the rising preference for generic drugs and biopharmaceuticals in emerging countries is boosting the demand for high-quality packaging solutions as they require stringent storage conditions. The increasing prevalence of chronic diseases, expanding pharmaceutical distribution networks, and growing healthcare lead to market growth. Thus driving the Pharmaceutical Glass Packaging market revenue. SGD Pharma, which had successfully run a campaign using 20% post-consumer recycled (PCR) glass at its Zhanjiang plant in China in September of the Year 2024. The purpose of this action is to lessen carbon footprints and minimize reliance on virgin raw materials in accordance with the global sustainability initiatives of SGD Pharm. This particular initiative not only provides solutions to the environmental concerns, but it also tackles the growing demand for eco-friendly packing in the cosmetics and pharmaceutical market. ## **Pharmaceutical Glass Packaging Market Segment Insights** ### **Pharmaceutical Glass Packaging Product Insights** The Asia Pacific Pharmaceutical Glass Packaging market segmentation, based on product, includes Vials & Ampoules, Bottles, Cartridges and Syringes. The bottles segment dominated the market due to its chemical inertness, superior protective, and rigidity qualities. Moreover, the bottles have attained preference in the packaging of solid and liquid pharmaceutical preparations like capsules, syrups, tablets, and ophthalmic products. On the other hand, the vials & ampoules category is expected to grow at a rapid CAGR as the entry of atmospheric gases like oxygen and CO2 is prevented in glass vials. Vials are inert, hence preventing the product from undergoing oxidation or hydrolysis. **Figure 1: Asia Pacific Pharmaceutical Glass Packaging Market, by Product, 2023 & 2032 (USD Billion)** **** Source: The Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Pharmaceutical Glass Packaging Drug Type Insights** The Asia Pacific Pharmaceutical Glass Packaging market segmentation, based on drug type, includes Generic, Branded, and Biologic. The generic category dominates the market. Generic drugs are comparatively of low price than branded drug products having similar composition. There is an increase in the promotion of using generic drugs as per the initiatives taken by the government. Further, the biological category is anticipated to grow due to its high effectiveness in the treatment of chronic and autoimmune diseases. ### **Pharmaceutical Glass Packaging Country Insights** The growth of pharmaceutical industries globally has resulted in a boom in demand for Pharmaceutical Glass Packaging in Asia Pacific in recent years. The increasing healthcare expenditure, fast urbanization, and rising pharmaceutical manufacturing activities in the countries of this region drive the demand for high-quality packaging solutions. Also, the rising prevalence of chronic diseases and the region's growing population drive the market growth. Technological advancements in glass manufacturing processes are improving the functionality and sustainability of glass packaging solutions and meeting the surging demands of the market. Moreover, the regulatory initiatives that promote domestic production and sustainability are also boosting market growth. Pharmaceutical glass packaging is opted for its inertness, non-reactivity, and impermeability to gases, ensuring the preservation of product efficacy and safety. **Figure 2: ASIA PACIFIC PHARMACEUTICAL GLASS PACKAGING MARKET SHARE BY REGION 2022 (USD Billion)** **** Source: The Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Pharmaceutical Glass Packaging Key Market Players & Competitive Insights** Leading market players are investing heavily in the research and development in order to extend their product lines, which will help the Pharmaceutical Glass Packaging market grow even more. Market participants are also undertaking different strategic activities to extend their footprint, with important market developments including contractual agreements, new product launches, mergers and acquisitions, higher investments, and collaboration with the other organizations. To expand and sustain in a more competitive and rising market climate, the Pharmaceutical Glass Packaging industry must offer cost-effective items. Peime players in the Pharmaceutical Glass Packaging market are trying to increase the market demand by investing in the research and development operations, including Saint-Gobain, Owens-Illinois, Inc., Amcor plc, Ardagh Group S.A., HEINZ-GLAS GmbH & Co. KGaA, BA GLASS GROUP, Bormioli Rocco S.p.A, Gerresheimer AG, Hindustan National Glass & Industries Limited. and KOA GLASS CO. LTD. ### **Key Companies in the Pharmaceutical Glass Packaging market include** ## **Pharmaceutical Glass Packaging Industry Developments** **March 2021:** A subsidiary of The Oneida Group, Anchor Hocking Glass Company's Monaca, Pennsylvania glass factory, was acquired by Stoelzle Glass Group. This acquisition helped the company start its seventh glass plant in the US and first outside Europe. In the year of 2023 when Gerresheimer AG started the cooperation with SCHOTT AG and Stevanato Group titled “Alliance for RTU” Ready-To-Use for pharmaceutical packaging. This alliance aims at enhancing efficiency of the ready-to-use/pre-sterilized packaging systems in Asia where pharmaceutical companies’ drug safety and delivery systems would be made perfect by this collaboration in the pharmaceutical sector. In October of the year 2023 Nippon Glass enlarged its activities in the territory of China by purchasing one of the local pharmaceutical glass packaging manufacturers. Such a step emphasizes the growing weight of the Chinese market for foreign companies as it houses a huge pharmaceutical market and a shift towards new safe packaging materials. According to the current estimates, as of October 2023, Gerresheimer AG, one of the leaders in the industry of pharmaceutical glass containers, managed to expand its constructor production facilities in China and reinforce its position on the fast-evolving market. Also, in Dec 2023, a Japanese company called Nipro Corporation launched the production of avant-garde glass containers for biopharmaceuticals, claiming the attention to glass packing innovation. ## **Pharmaceutical Glass Packaging Market Segmentation** ### **Pharmaceutical Glass Packaging Product Outlook** ### **Pharmaceutical Glass Packaging Drug Type Outlook** ### **Pharmaceutical Glass Packaging Regional Outlook** ## Market Drivers ### Rising Demand for Biopharmaceuticals The increasing prevalence of chronic diseases and the growing focus on personalized medicine are driving the demand for biopharmaceuticals in the APAC region. This trend is likely to enhance the pharmaceutical glass-packaging market, as biopharmaceuticals often require specialized packaging solutions to maintain stability and efficacy. The market for biopharmaceuticals in APAC is projected to grow at a CAGR of approximately 8% from 2025 to 2030, indicating a robust demand for [glass packaging](https://www.marketresearchfuture.com/reports/glass-packaging-market-1258) that can ensure product integrity. Pharmaceutical glass-packaging market players are thus focusing on developing innovative glass solutions that cater to the unique requirements of biopharmaceuticals, including features like break resistance and compatibility with various drug formulations. ### Emergence of Smart Packaging Solutions The pharmaceutical glass-packaging market is witnessing a trend towards smart packaging solutions that incorporate technology to enhance user experience and product safety. Innovations such as QR codes, NFC tags, and temperature indicators are being integrated into glass packaging to provide real-time information about the product. This trend is particularly relevant in the APAC region, where consumers are becoming increasingly tech-savvy and demand transparency regarding their medications. The adoption of smart packaging is expected to grow, as it not only improves patient adherence but also helps manufacturers track product distribution and ensure compliance with regulatory standards. This evolution in packaging technology could significantly impact the market dynamics in the coming years. ### Growing Focus on Drug Safety and Efficacy As the pharmaceutical industry in APAC continues to evolve, there is an increasing emphasis on drug safety and efficacy. This focus is driving the demand for high-quality packaging solutions that can protect medications from contamination and degradation. The pharmaceutical glass-packaging market is responding by developing advanced glass materials that offer superior barrier properties and chemical resistance. With regulatory bodies tightening standards for drug packaging, manufacturers are likely to invest in innovative glass solutions that meet these stringent requirements. This trend is expected to propel the market forward, as companies seek to enhance their product offerings and ensure compliance with safety regulations. ### Expansion of E-commerce in Pharmaceuticals The rise of e-commerce in the pharmaceutical sector is reshaping the distribution landscape in APAC. As online pharmacies gain traction, the need for secure and reliable packaging solutions becomes paramount. The pharmaceutical glass-packaging market is likely to experience growth as e-commerce platforms demand packaging that can withstand the rigors of shipping while ensuring product safety. This shift towards online sales is expected to increase the volume of packaged pharmaceuticals, thereby driving demand for glass packaging that can provide the necessary protection during transit. Companies are thus exploring innovative designs and materials to cater to this evolving market. ### Increased Investment in Healthcare Infrastructure The APAC region is witnessing substantial investments in healthcare infrastructure, driven by government initiatives and private sector participation. This surge in investment is expected to bolster the pharmaceutical glass-packaging market, as enhanced healthcare facilities require reliable packaging solutions for pharmaceuticals. For instance, countries like India and China are expanding their healthcare systems, which is likely to increase the demand for glass packaging materials. The pharmaceutical glass-packaging market is poised to benefit from this trend, as manufacturers align their production capabilities to meet the growing needs of healthcare providers, ensuring that they can deliver safe and effective medications to patients. ## Future Outlook The pharmaceutical glass-packaging market is projected to grow at a 7.13% CAGR from 2025 to 2035, driven by increasing demand for biologics and sustainable packaging solutions. **New opportunities:** - Investment in smart packaging technologies for enhanced drug traceability. Expansion of production facilities to meet rising demand in emerging markets. Development of eco-friendly glass materials to attract environmentally conscious clients. By 2035, the market is expected to achieve robust growth, driven by innovation and sustainability. ## Segment Insights ### By Application: Vials (Largest) vs. Bottles (Fastest-Growing) In the APAC pharmaceutical glass packaging market, vials represent the largest segment, capturing a significant portion of the market share due to their widespread use in the packaging of vaccines, injectables, and other sensitive pharmaceuticals. Bottles, while currently smaller in share, have shown substantial growth driven by the increasing demand for oral liquid medications and health supplements. This distribution highlights the essential role that glass packaging plays in preserving the integrity of pharmaceutical products, catering to various application needs within the industry. The growth trends in this segment are influenced by several factors, including the rising prevalence of chronic diseases that require efficient pharmacy solutions. The increasing focus on biologics and the need for safe and effective packaging solutions contribute to the surge in demand for vials and bottles. Furthermore, regulatory support for glass packaging in pharmaceuticals bolsters market opportunities, particularly in emerging economies, thereby shaping future growth prospects. Vials (Dominant) vs. Cartridges (Emerging) Vials dominate the APAC pharmaceutical glass packaging market as they are integral in storing and delivering injectables, particularly in the increasing segment of biologics and vaccines. Their design allows optimal protection against environmental factors, ensuring that medicines maintain their efficacy. Conversely, cartridges have emerged as a growing alternative, particularly in the sector of prefilled syringes. They offer advantages such as convenience and precision in drug delivery, appealing to a segment of the market that increasingly favors self-administration options. As digital health solutions and patient-centric drug delivery methods rise, cartridges are seen as a flexible option that complements vials, thus diversifying the pharmaceutical glass packaging landscape. ### By End Use: Pharmaceuticals (Largest) vs. Biotechnology (Fastest-Growing) In the APAC pharmaceutical glass packaging market, the distribution among end use segments is characterized by significant dominance of the pharmaceuticals sector, which commands a major share. This segment is driven by the increasing demand for high-quality, reliable packaging solutions that ensure the integrity and safety of medications. Following closely is the biotechnology segment, which is rapidly gaining momentum owing to advancements in biopharmaceuticals and a growing number of biotechnology products entering the market. Pharmaceuticals (Dominant) vs. Biotechnology (Emerging) The pharmaceuticals segment remains the dominant player in the APAC pharmaceutical glass packaging landscape due to its extensive usage in the packaging of a wide range of drug formulations. This segment benefits from stringent regulations that require safe and effective packaging solutions. Conversely, the biotechnology segment, labeled as emerging, is witnessing robust growth fueled by innovation in drug development and a greater emphasis on biologics. This segment’s demand for specialized glass packaging, which can preserve the efficacy of sensitive biopharmaceuticals, is presenting new opportunities for manufacturers and driving market evolution. ### By Material Type: Borosilicate Glass (Largest) vs. Lead Glass (Fastest-Growing) In the APAC pharmaceutical glass packaging market, Borosilicate Glass holds a dominant market share, attributed to its favorable thermal resistance and chemical durability. Its ability to withstand high temperatures and corrosive substances makes it a preferred choice among pharmaceutical manufacturers for packaging various medicinal products. On the other hand, Soda-Lime Glass also plays a significant role, particularly in economically sensitive segments, though it lacks the superior properties of Borosilicate Glass. Notably, Lead Glass is emerging as the fastest-growing segment, driven by increasing demand for high-quality packaging solutions that provide better protection against environmental factors. This segment's growth can be linked to the rising trend in personalized medicines and specialty pharmaceuticals, which require enhanced packaging solutions to maintain product integrity. As manufacturers seek higher-quality materials for their packaging needs, Lead Glass is positioned to capture a larger share of the market moving forward. Borosilicate Glass (Dominant) vs. Lead Glass (Emerging) Borosilicate Glass is recognized for its superior resistance to thermal shock and chemical leaching, making it ideal for the pharmaceutical industry, where product integrity is paramount. It is extensively used in vials, ampoules, and syringes, catering to the stringent safety standards of the market. On the other hand, Lead Glass, characterized by its high clarity and brilliance, is gaining traction as an emerging material in pharmaceutical packaging. It is particularly suited for high-precision applications where visibility and protection from UV radiation are critical. This segment's rise reflects a growing preference among manufacturers for innovative, high-quality packaging solutions that not only meet regulatory requirements but also enhance user experience. ### By Closure Type: Screw Caps (Largest) vs. Dropper Caps (Fastest-Growing) In the APAC pharmaceutical glass packaging market, screw caps have established themselves as the largest segment, providing reliable sealing solutions across a range of pharmaceutical products. Their ease of use and effectiveness in securing contents make them the preferred choice among manufacturers, contributing to their significant market share. On the other hand, dropper caps are emerging rapidly, particularly in the packaging of liquid pharmaceuticals, where dosage precision is crucial. This segment's growth is fueled by increasing demand from the healthcare sector for more precise and user-friendly dispensing methods. Screw Caps (Dominant) vs. Dropper Caps (Emerging) Screw caps represent the dominant force within the closure type segment of the APAC pharmaceutical glass packaging market, known for their robust design that ensures product integrity and extends shelf life. These closures are versatile and compatible with various pharmaceutical formulations, driving their widespread adoption. Conversely, dropper caps are gaining traction as an emerging segment, particularly favored for liquid formulations that require accurate dosing. Their design addresses consumer needs for precision and convenience, thereby expanding their usage in niche applications within the pharmaceuticals market. ### By Capacity: 10ml to 50ml (Largest) vs. More than 100ml (Fastest-Growing) In the APAC pharmaceutical glass packaging market, the capacity segment is crucial in determining preferences for packaging solutions. The '10ml to 50ml' category holds the largest market share, driven by its versatility for a range of products including vaccines, serums, and other liquid medications. In contrast, the 'More than 100ml' segment is rapidly gaining traction, particularly for larger formulations needed in hospitals and clinics. This shift is indicative of the changing landscape of pharmaceutical applications, wherein larger volumes are becoming more common. As the pharmaceutical industry in APAC continues to expand, the demand for glass packaging solutions is also on the rise. The growth of the 'More than 100ml' segment can be attributed to an increasing focus on bulk packaging for biologics and complex medicines. Emerging trends such as the rise in chronic diseases and the growing popularity of targeted therapies further fuel this growth, prompting manufacturers to invest in larger capacity solutions to meet evolving healthcare demands. 10ml to 50ml (Dominant) vs. More than 100ml (Emerging) The '10ml to 50ml' segment of the APAC pharmaceutical glass packaging market is characterized by its dominance, primarily due to its wide application across injectable drugs and biologics. This capacity range allows for a suitable balance between dosage precision and ease of handling, making it a preferred choice among pharmaceutical companies. In contrast, the 'More than 100ml' segment is emerging as a critical player, driven by the increasing demand for larger volume packages that accommodate complex drug formulations. This trend is reinforced by the demand for cost-effective solutions in bulk supply, particularly in healthcare settings. As both segments continue to evolve, attention to quality, sustainability, and regulatory compliance will be pivotal in strengthening their market positions. ## Regional Market Share Analysis ### China : Unmatched Growth and Demand Trends China holds a commanding market share of 40% in the APAC pharmaceutical glass-packaging sector, valued at $3000.0 million. Key growth drivers include a booming pharmaceutical industry, increasing healthcare expenditure, and a rising demand for biologics and vaccines. Regulatory policies favoring local production and stringent quality standards further bolster market growth. Infrastructure improvements and industrial development initiatives are enhancing manufacturing capabilities, making China a hub for [pharmaceutical packaging](https://www.marketresearchfuture.com/reports/pharmaceutical-packaging-market-1291). ### India : Healthcare Growth Fuels Demand Key markets include Maharashtra and Gujarat, where major pharmaceutical companies are located. The competitive landscape features players like Schott AG and Gerresheimer AG, which have established manufacturing facilities. The local business environment is favorable, with supportive policies and a growing emphasis on sustainable packaging solutions. The biopharmaceutical industry is a significant sector driving demand for glass packaging. ### Japan : Technological Advancements Drive Growth Key markets include Tokyo and Osaka, where major pharmaceutical firms are concentrated. The competitive landscape is characterized by strong players like Nipro Corporation and Schott AG, which lead in innovation and quality. The local market dynamics favor high-end packaging solutions, with a focus on biologics and specialty drugs. The pharmaceutical sector's growth is closely tied to advancements in packaging technologies, enhancing product safety and shelf life. ### South Korea : Strong Regulatory Support and Innovation Key markets include Seoul and Incheon, where major pharmaceutical companies are based. The competitive landscape features significant players like Corning Inc and Gerresheimer AG, which are known for their innovative packaging solutions. The local business environment is conducive to growth, with a focus on sustainability and advanced manufacturing technologies. The biopharmaceutical industry is a key driver of demand for glass packaging solutions. ### Malaysia : Government Initiatives Boost Market Key markets include Selangor and Penang, where many pharmaceutical companies are located. The competitive landscape features players like Stölzle-Oberglas GmbH and local manufacturers. The business environment is favorable, with supportive government policies and a focus on innovation. The pharmaceutical sector's growth is closely linked to advancements in packaging technologies, enhancing product safety and efficacy. ### Thailand : Investment in Healthcare Infrastructure Key markets include Bangkok and Chonburi, where major pharmaceutical companies are concentrated. The competitive landscape features players like Ardagh Group and local manufacturers. The local business environment is supportive, with a focus on sustainability and innovation. The pharmaceutical sector's growth is closely tied to advancements in packaging technologies, enhancing product safety and shelf life. ### Indonesia : Healthcare Demand Drives Growth Key markets include Jakarta and Surabaya, where many pharmaceutical companies are located. The competitive landscape features players like Nipro Corporation and local manufacturers. The local business environment is improving, with supportive government policies and a focus on innovation. The pharmaceutical sector's growth is closely linked to advancements in packaging technologies, enhancing product safety and efficacy. ### Rest of APAC : Varied Demand Across Sub-regions Key markets include Vietnam and the Philippines, where local pharmaceutical industries are expanding. The competitive landscape features a mix of local and international players, each catering to specific market needs. The business environment is diverse, with varying levels of regulatory support and infrastructure development. The pharmaceutical sector's growth is closely tied to local healthcare demands and advancements in packaging technologies. ## Competitive Benchmarking The [pharmaceutical](https://www.marketresearchfuture.com/categories/pharmaceutical-market-report)glass-packaging market is currently characterized by a dynamic competitive landscape, driven by increasing demand for high-quality packaging solutions that ensure product integrity and safety. Key players such as Schott AG (Germany), Corning Inc (US), and Gerresheimer AG (Germany) are strategically positioned to leverage innovation and technological advancements. Schott AG (Germany) focuses on developing specialized glass solutions that cater to the pharmaceutical sector, emphasizing sustainability and efficiency in production. Corning Inc (US) has been enhancing its product portfolio through advanced materials science, while Gerresheimer AG (Germany) is expanding its manufacturing capabilities to meet the growing needs of the market. Collectively, these strategies contribute to a competitive environment that prioritizes quality, innovation, and responsiveness to market demands.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach appears to be particularly effective in the APAC region, where demand for pharmaceutical glass packaging is on the rise. The market structure is moderately fragmented, with several key players exerting influence over pricing and product offerings. The collective actions of these companies indicate a trend towards consolidation, as they seek to enhance their market positions through strategic partnerships and acquisitions. In October Schott AG (Germany) announced a partnership with a leading pharmaceutical company to develop a new line of eco-friendly glass vials. This collaboration is significant as it aligns with the growing emphasis on sustainability within the industry, potentially setting a new standard for environmentally responsible packaging solutions. The partnership not only enhances Schott's product offerings but also reinforces its commitment to sustainable practices, which may resonate well with environmentally conscious consumers and stakeholders. In September Corning Inc (US) unveiled a state-of-the-art manufacturing facility in Asia, aimed at increasing production capacity for its pharmaceutical glass products. This strategic move is likely to bolster Corning's presence in the APAC market, allowing for quicker response times to customer demands and enhancing supply chain efficiency. The facility is expected to utilize advanced automation technologies, which could further improve production quality and reduce operational costs. In August Gerresheimer AG (Germany) expanded its operations in Japan by acquiring a local glass manufacturing company. This acquisition is indicative of Gerresheimer's strategy to strengthen its foothold in the APAC region, enabling it to better serve local pharmaceutical clients. The integration of local expertise and resources may enhance Gerresheimer's competitive edge, allowing for tailored solutions that meet specific regional needs. As of November current trends in the pharmaceutical glass-packaging market include a strong focus on digitalization, sustainability, and the integration of AI technologies. These trends are reshaping the competitive landscape, as companies seek to differentiate themselves through innovative solutions rather than solely competing on price. Strategic alliances are becoming increasingly important, facilitating knowledge sharing and resource optimization. Looking ahead, it appears that competitive differentiation will evolve, with a greater emphasis on technological advancements, supply chain reliability, and sustainable practices, ultimately transforming the market dynamics. ## Recent News & Developments **March 2021:** A subsidiary of The Oneida Group, Anchor Hocking Glass Company's Monaca, Pennsylvania glass factory, was acquired by Stoelzle Glass Group. This acquisition helped the company start its seventh glass plant in the US and first outside Europe. In the year of 2023 when Gerresheimer AG started the cooperation with SCHOTT AG and Stevanato Group titled “Alliance for RTU” Ready-To-Use for pharmaceutical packaging. This alliance aims at enhancing efficiency of the ready-to-use/pre-sterilized packaging systems in Asia where pharmaceutical companies’ drug safety and delivery systems would be made perfect by this collaboration in the pharmaceutical sector. In October of the year 2023 Nippon Glass enlarged its activities in the territory of China by purchasing one of the local pharmaceutical glass packaging manufacturers. Such a step emphasizes the growing weight of the Chinese market for foreign companies as it houses a huge pharmaceutical market and a shift towards new safe packaging materials. According to the current estimates, as of October 2023, Gerresheimer AG, one of the leaders in the industry of pharmaceutical glass containers, managed to expand its constructor production facilities in China and reinforce its position on the fast-evolving market. Also, in Dec 2023, a Japanese company called Nipro Corporation launched the production of avant-garde glass containers for biopharmaceuticals, claiming the attention to glass packing innovation. ## Report Scope | MARKET SIZE 2024 | 8019.57(USD Million) | | --- | --- | | MARKET SIZE 2025 | 8591.37(USD Million) | | MARKET SIZE 2035 | 17100.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.13% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Schott AG (DE), Corning Inc (US), Gerresheimer AG (DE), Nipro Corporation (JP), Owen Mumford Ltd (GB), Ardagh Group (IE), Stölzle-Oberglas GmbH (AT), Saverglass (FR) | | Segments Covered | Product Type, Material Type, Application | | Key Market Opportunities | Adoption of sustainable materials in the pharmaceutical glass-packaging market enhances compliance with evolving environmental regulations. | | Key Market Dynamics | Rising demand for sustainable packaging solutions drives innovation in the pharmaceutical glass-packaging market. | | Countries Covered | China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC | ## Frequently Asked Questions **Q: What is the current valuation of the APAC pharmaceutical glass packaging market?** A: The market valuation reached approximately 8019.57 USD Million in 2024. **Q: What is the projected market size for the APAC pharmaceutical glass packaging market by 2035?** A: The market is expected to grow to around 17444.13 USD Million by 2035. **Q: What is the expected CAGR for the APAC pharmaceutical glass packaging market during the forecast period?** A: The market is anticipated to experience a CAGR of 7.32% from 2025 to 2035. **Q: Which companies are considered key players in the APAC pharmaceutical glass packaging market?** A: Key players include Schott AG, Gerresheimer AG, Nipro Corporation, and Amcor plc, among others. **Q: What are the primary applications of pharmaceutical glass packaging in the APAC region?** A: The main applications include vials, ampoules, bottles, and cartridges. **Q: How does the market segment by end use in the APAC pharmaceutical glass packaging market?** A: The market segments include pharmaceuticals, biotechnology, nutraceuticals, and cosmetics. **Q: What types of glass materials are predominantly used in pharmaceutical packaging?** A: Borosilicate glass, soda-lime glass, and lead glass are the primary materials utilized. **Q: What closure types are commonly used in pharmaceutical glass packaging?** A: Common closure types include screw caps, dropper caps, and crimped caps. **Q: How is the capacity of pharmaceutical glass packaging categorized in the APAC market?** A: Capacity is categorized into less than 10ml, 10ml to 50ml, 50ml to 100ml, and more than 100ml. **Q: What trends are influencing the growth of the APAC pharmaceutical glass packaging market?** A: Trends include increasing demand for biopharmaceuticals and advancements in packaging technology. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/apac-pharmaceutical-glass-packaging-market-21658*